AGO TUMOR CAN BE FUN FOR ANYONE

Proven immune markers continue to preserve their relevance for clinical choice-creating in breast cancer treatment method with even prolonged meanings. Estrogen receptor (ER) level must not only be classified in optimistic or detrimental. Small ER concentrations ≤10% of labeled cells must be managed in another way (LoE 1a/A/AGO++). Tumors with re